Resmetirom FDA approval date

The FDA approved Resmetirom (MGL-3196) on 14 Mar 2024.

FDA approval date
14 Mar 2024

Drug identity checked against registry records

Also recorded as MGL-3196

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-03-14DayResmetiromFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217785", "applicant_as_listed_by_fda": "MADRIGAL", "brand_names": ["REZDIFFRA"], "active_ingredients": ["RESMETIROM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240314", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026